Foghorn Therapeutics (FHTX) Other Working Capital Changes (2020 - 2026)

Foghorn Therapeutics' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$3.3 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes rose 45.1% year-over-year to -$3.3 million; the TTM figure through Mar 2026 stood at -$25.4 million (down 7.9% YoY), while the FY2025 annual figure was -$30.9 million, down 36.75% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$3.3 million, up from -$21.3 million in the prior quarter.
• The five-year high for Other Working Capital Changes was $1.4 million in Q4 2022, with the low at -$1.3 million in Q3 2025.
• The 5-year median for Other Working Capital Changes is -$465000.0 (2024), against an average of -$263941.2.
• Peak annual rise in Other Working Capital Changes reached 598.97% in 2023, while the deepest fall reached 1419.09% in 2023.
• Foghorn Therapeutics' Other Working Capital Changes stood at -$4.2 million in 2022, then surged by 598.97% to $20.9 million in 2023, then sank by 113.68% to -$2.9 million in 2024, then sank by 645.8% to -$21.3 million in 2025, then surged by 84.66% to -$3.3 million in 2026.
• Business Quant data shows FHTX's Other Working Capital Changes at -$3.3 million in Q1 2026, -$21.3 million in Q4 2025, and $7.7 million in Q3 2025.